Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Immunity to seasonal and pandemic influenza A viruses.

Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K.

Microbes Infect. 2011 May;13(5):489-501. doi: 10.1016/j.micinf.2011.01.007. Epub 2011 Feb 2. Review.

2.

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2013 Mar;94(Pt 3):583-92. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.

PMID:
23152369
3.

Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.

Gras S, Kedzierski L, Valkenburg SA, Laurie K, Liu YC, Denholm JT, Richards MJ, Rimmelzwaan GF, Kelso A, Doherty PC, Turner SJ, Rossjohn J, Kedzierska K.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12599-604. doi: 10.1073/pnas.1007270107. Epub 2010 Jun 28.

5.

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.

6.

Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Fang Y, Banner D, Kelvin AA, Huang SS, Paige CJ, Corfe SA, Kane KP, Bleackley RC, Rowe T, Leon AJ, Kelvin DJ.

J Virol. 2012 Feb;86(4):2229-38. doi: 10.1128/JVI.05540-11. Epub 2011 Nov 30.

7.

Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.

Zhong W, Liu F, Dong L, Lu X, Hancock K, Reinherz EL, Katz JM, Sambhara S.

PLoS One. 2010 May 11;5(5):e10583. doi: 10.1371/journal.pone.0010583.

8.

CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, Treanor JJ, Topham DJ.

Vaccine. 2011 Mar 3;29(11):2159-68. doi: 10.1016/j.vaccine.2010.12.073. Epub 2011 Jan 4.

9.

Swine influenza virus antibodies in humans, western Europe, 2009.

Gerloff NA, Kremer JR, Charpentier E, Sausy A, Olinger CM, Weicherding P, Schuh J, Van Reeth K, Muller CP.

Emerg Infect Dis. 2011 Mar;17(3):403-11. doi: 10.3201/eid1703.100851.

10.
11.

T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.

Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ.

J Virol. 2011 Jan;85(1):448-55. doi: 10.1128/JVI.01812-10. Epub 2010 Oct 27.

12.

Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.

Baz M, Papenburg J, Hamelin ME, Ouakki M, Skowronski DM, De Serres G, Boivin G.

Emerg Infect Dis. 2012 Jul;18(7):1132-4. doi: 10.3201/eid1807.111680.

13.

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.

Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, Gubbay J, Rebbapragada A, Winter AL, Achonu C, Ward BJ, Watts TH.

PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.

14.

Host response to influenza virus: protection versus immunopathology.

Peiris JS, Hui KP, Yen HL.

Curr Opin Immunol. 2010 Aug;22(4):475-81. doi: 10.1016/j.coi.2010.06.003. Epub 2010 Jun 30. Review.

15.

Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.

Zhang XS, De Angelis D, White PJ, Charlett A, Pebody RG, McCauley J.

Epidemics. 2013 Mar;5(1):20-33. doi: 10.1016/j.epidem.2012.10.003. Epub 2012 Nov 6.

PMID:
23438428
16.

Serological survey of antibodies to influenza A viruses in a group of people without a history of influenza vaccination.

Chen Y, Zheng Q, Yang K, Zeng F, Lau SY, Wu WL, Huang S, Zhang J, Chen H, Xia N.

Clin Microbiol Infect. 2011 Sep;17(9):1347-9. doi: 10.1111/j.1469-0691.2011.03538.x. Epub 2011 Jul 13.

17.

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.

PLoS One. 2012;7(8):e42363. doi: 10.1371/journal.pone.0042363. Epub 2012 Aug 7.

18.

Immune responses to influenza virus infection.

Kreijtz JH, Fouchier RA, Rimmelzwaan GF.

Virus Res. 2011 Dec;162(1-2):19-30. doi: 10.1016/j.virusres.2011.09.022. Epub 2011 Sep 22. Review.

PMID:
21963677
19.

Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.

Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, Tsukamoto Y.

Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.

PMID:
21468553
20.

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.

Schmidt T, Dirks J, Enders M, Gärtner BC, Uhlmann-Schiffler H, Sester U, Sester M.

Eur J Immunol. 2012 Jul;42(7):1755-66. doi: 10.1002/eji.201242393.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk